OpenDrugData

Open Drug Data License

These terms are the license for Open Drug Data (opendrugdata.com) and the materials it delivers. By using the site, creating an account, paying for a subscription, downloading a release, or calling the API, you agree to them.

Licensor. The owners and operators of Open Drug Data (opendrugdata.com) ("Open Drug Data," "we," "us").

Customer. The team that holds the subscription, and the people who act for it ("you").

Materials. Everything Open Drug Data makes available under a paid SKU: the Portal, the Catalog API and its results, Embedded search, and the ODD, ODDVET, and PDMP release files, including identifiers such as oddvet:V..., private indexes built from them, and edits of them.

SKUs

You are licensed only for the SKUs your team is currently paying for. Each SKU is separate:

SKU What it covers
Portal The signed-in app: catalog, search, guide, and docs. Browser sessions that call /api/v1 are logged as Portal usage.
Catalog API /api/v1 for API keys, volume priced (see below). A Catalog API subscription also allows a browser session; that session is still logged as Portal usage.
Embedded search Search presets, the public embed, and delegated JWTs that call /api/v1, volume priced (see below).
Catalog downloads ODD release files
ODDVET Files ODDVET release files
PDMP Files PDMP release files

Volume pricing

The Catalog API and Embedded search each include a query allowance for each billing period. Each allowance is the number shown for your team in billing for that SKU (your team's own allowance when set, otherwise the published default for that SKU).

API key queries count toward the Catalog API allowance. Delegated JWT queries count toward the Embedded search allowance, not the Catalog API allowance. Queries past a SKU's allowance are billed at that SKU's metered volume price.

Signed-in browser sessions are recorded as Portal usage. They do not count toward either allowance or its volume charges. A browser session may call /api/v1 when the team holds Portal or the Catalog API.

Unpaid base fees and unpaid volume charges each end the license for that SKU.

License grant

While you hold a current paid subscription for a SKU, Open Drug Data grants you a limited, non-exclusive, non-transferable, non-sublicensable license to use the Materials for that SKU for your team's own internal business purposes, subject to these terms.

Edits

You may reformat, filter, and load the files into your own systems. Edits remain Materials under this license. You do not own them.

Real-Time Use

Real-time query, lookup, retrieval, tool calls, and retrieval-augmented generation are allowed and encouraged. You may look the Materials up at the time of a question and show the answer to the person who asked. A private index kept only to serve those live queries is part of that use. That index is not a separate product and may not be published or given to anyone else.

Restrictions

No Redistribution

You may not share, resell, sublicense, publicly post, or ship the files, a bulk extract, or the identifiers as a dataset other people keep. Employees and contractors may use the Materials only for your team's own work, under a written duty at least as strict as these terms, and may not keep copies after that work ends.

No Deriving

You may not build a new vocabulary, crosswalk, database, or product from the Materials, other than the edits and the private live-query index described above. Those stay inside your team.

No Training

You may not train, fine-tune, or otherwise build a model from the Materials, and you may not make a benchmark or evaluation set so a model can absorb them. A live lookup at question time is not training.

Payment

A current paid subscription for a SKU is a condition of that SKU's license. A failed, reversed, or missing payment ends that SKU immediately. Other paid SKUs continue. For the Catalog API and Embedded search, unpaid volume charges are a missed payment. When a SKU ends, use of its Materials must stop, and you must delete copies, edits, caches, and private indexes for that SKU within 15 days. The restrictions in these terms and the loss clause survive.

Abuse

Open Drug Data may end one SKU or every SKU immediately if the Materials or the service are being abused. Redistribution is abuse even when you did not know about it, including a leak by someone on your team, a contractor, or a compromised system. Not knowing is not a defense to ending the license or to the loss calculation. Ending a license for abuse does not require a refund. The deletion duty still applies.

Upstream

Credits in NOTICE stay. This license does not claim U.S. government works. Files you obtain independently from FDA or NLM are outside this license. Files you obtain from Open Drug Data stay under this license even where an upstream license is looser. Nothing here grants a right an upstream withholds.

Leak or misuse

If you breach the redistribution, deriving, or training restrictions, or if the Materials leak as described under Abuse, you agree to pay Open Drug Data a loss calculated by the operators as follows.

Formula. F × R.

  • For a flat SKU, F is twelve times its monthly price.
  • For the Catalog API and Embedded search, F is that SKU's base fees plus its volume charges for the twelve months before the breach.
  • If you were not paying, F uses the then-current public price of the SKU that covered the Materials (for the Catalog API and Embedded search, the public base price plus the volume price applied to the volume involved).
  • R is the number of people or organizations outside your team who received the files, a bulk extract, a derivative vocabulary, or a model trained on the Materials, and is at least 1.
  • A live answer to a person who asked a question does not count toward R.
  • A public posting with an unknown audience uses the number of recipients the operators can establish; R is 1 only when none can be established.

The operators' count of R and calculation of F control, except for an arithmetic error you dispute in writing within 30 days. The amount is in addition to unpaid fees, is outside the general liability cap, and does not replace an injunction.

No advice; disclaimer; liability

The Materials are not veterinary, medical, or dispensing advice. They are provided as is, without warranties of any kind. Open Drug Data's ordinary liability under these terms is capped at the fees you paid for the affected SKUs in the twelve months before the claim. You will defend and pay claims arising from your breach of these terms or from your use of the Materials.

Governing law

These terms are governed by the laws of the State of California, without regard to conflict-of-law rules.